Parenteral Drug Association filed 3 comments on this docket between Mar 4, 2010 and Jun 1, 2020. 0 other organizations filed here. The comment window closed 5732d ago.
Please find attached the comments of the Parenteral Drug Association, updated to reflect lessons learned in the current coronavirus pandemic emergency. Thank you for the opportunity to provide input to this guidance again.
Filed on regulations.gov — full text not in the inline record.
On behalf of the Parenteral Drug Association (PDA), we are pleased to submit our comments to you on FDA's Draft Guidance in the matter of "Industry on Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products.
Status: OPEN
View on regulations.gov →